Skip to main content
. 2017 Apr 19;27(4):441–448. doi: 10.1007/s00590-017-1957-1

Table 5.

Summary-1

Authors Study design Age Sex M: F Previous treatment Intervention Pt had surgery Final analysis Level of study
Chan et al. [21] Case series retrospective 37.2 (24–58) 26:4 Yes HVIGI
10 mL 0.5% bupivacaine
25 mg hydrocortisone
4 × 10 ml of normal saline
0 21 IV
Humphrey et al. [22] Case series prospective 43.5 ± 11.6 7:4 Yes HVIGI
10 mL 0.5% bupivacaine
25 mg hydrocortisone
4 × 10 mL normal saline
0 11 IV
Maffulli et al. [20] Case series prospective 37.5 (2263) 69:25 Yes HVIGI
10 ml 0.25% bupivacaine
62,500 U aprotinin
8 87 IV
Wheeler et al. [23] Case series retrospective two groups 50.6 ± 11.3 14:20 Yes Group 1: 10 ml 1% lidocaine +40 ml N/saline
HVIGI
Group 2: dry needling + HVIGI. 10 ml 1% lidocaine
+20 ml N/saline
Group 1:3
Group 2:6
34 III.